Yann Mazabraud's Net Worth
$2.6 Million
Who is Yann Mazabraud?
Yann Mazabraud has an estimated net worth of $2.6 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., and Trevi Therapeutics, Inc..
SEC CIK
Yann Mazabraud's CIK is 0001774702
Past Insider Trading and Trends
2024 was Yann Mazabraud's most active year for acquiring shares with 7 total transactions. Yann Mazabraud's most active month to acquire stocks was the month of January. 2024 was Yann Mazabraud's most active year for disposing of shares, totalling 9 transactions. Yann Mazabraud's most active month to dispose stocks was the month of January. 2020 saw Yann Mazabraud paying a total of $0.00 for 170,000 shares, this is the most they've acquired in one year. In 2024 Yann Mazabraud cashed out on 53,675 shares for a total of $757,116.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
EVP, Head International
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.93% | -10.38K |
—
|
—
| 34.87K |
Apr 14 - Apr 15
| |||
Form 4
| -39.51% | -16.00K |
$39.22 | -$627,520.00 | 24.5K |
Mar 19
| |||
Form 4
| +500.37% | 33.75K |
—
|
—
| 40.49K |
Feb 16
| |||
Form 4
| +76.25% | 2.92K |
$50.80 | -$129,596.60 | 6.75K |
Feb 9 - Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
| -23.52% | -1.18K |
$27.03 | -$31,814.31 | 3.83K |
Scheduled
|
Feb 14
| ||
Form 4
| +68.31% | 2.03K |
—
|
—
| 5K |
Feb 11
| |||
Form 4/A
| -34.46% | -1.56K |
$27.51 | -$42,998.13 | 2.97K |
Scheduled
|
Feb 9
| ||
Form 4
| +172.13% | 1.89K |
$27.66 | -$42,817.68 | 2.99K |
Scheduled
|
Feb 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 1.1K |
$6.10 | -$5,697.40 | 1.1K |
Scheduled
|
Feb 11 - Feb 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $2.95
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||